Transparent, global reporting by Semafor journalists on politics, policy, business, finance, technology, climate, energy, media, entertainment, world affairs, China, Asia, Europe, Africa for US and international readers.

  • 535articles · 30d
  • 37+ min agolatest article
  • Aug 14, 2026earliest in window
  • 98%with images
  • 192avg words
articles per day
Categories
  • News 295
  • Economy, Business & Finance 230
  • Politics 211
  • Finance & Business 168
  • Politics2 136
  • Conflict, War & Peace 58
  • Business & Industrial 54
  • Science & Technology 54

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

semafor.com
semafor.com > article > 08 > 20 > 2026 > tempus-ais-biotech-deal-attracts-investor-attention

Tempus AI’s biotech deal attracts investor attention

3+ week, 2+ day ago   (208+ words) The deal would have passed by without much notice, but Personalis’ technology is crucial to building the revolutionary personalized cancer therapies announced earlier this week by Merck and Moderna. Tempus AI’s biotech deal attracts investor attention A tiny biotech deal…...